STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40 T/t-Antigen Transgenic Mice

• Florence Meyer-Losic,

  Affiliation IPSEN Innovation, IPSEN, Paris, France

  ⨯
• Simon P. Newman,

  Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom

  ⨯
• Joanna M. Day,

  Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom

  ⨯
• Michael J. Reed †,

  † Deceased.

  Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom

  ⨯
• Philip G. Kasprzyk,

  Affiliation Ipsen Biomeasure, IPSEN, Milford, Massachusetts, United States of America

  ⨯
• Atul Purohit,

  Affiliation Oncology Drug Discovery and Women's Health Group, Imperial College London, London, United Kingdom

  ⨯
• Paul A. Foster

  * E-mail: p.a.foster@bham.ac.uk

  Affiliation Centre for Endocrinology, Diabetes and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, United Kingdom

  ⨯